Pathway Capital Management, LP Quanterix Corp Transaction History

Pathway Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$37.54 - $57.51 $3.02 Million - $4.63 Million	-80,454 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$45.91 - $59.67 $3.69 Million - $4.8 Million	80,454 New	80,454 $4.01 Million
Q2 2021 Aug 13, 2021	SELL	$43.3 - $67.17 $2.38 Million - $3.69 Million	-54,946 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$44.11 - $90.64 $2.23 Million - $4.59 Million	50,646 Added 1177.81%	54,946 $3.21 Million
Q4 2020 Feb 10, 2021	BUY	$33.89 - $49.88 $145,727 - $214,484	4,300 New	4,300 $200,000

159

32.1M

39K

5.5K

Ticker QTRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,987,600
Market Cap $440M
Description
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...

Get notified when there are updates to the investment portfolio of Pathway Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Pathway Capital Management, LP with notifications on news.